Tactile Systems Technology (Tactile Systems Technology) Cash, Cash Equivalents, Marketable Securities : $75.0 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Tactile Systems Technology Cash, Cash Equivalents, Marketable Securities?

Tactile Systems Technology's quarterly cash, cash equivalents, marketable securities declined from Sep. 2023 ($79.64 Mil) to Dec. 2023 ($75.23 Mil) but then stayed the same from Dec. 2023 ($75.23 Mil) to Mar. 2024 ($75.03 Mil).

Tactile Systems Technology's annual cash, cash equivalents, marketable securities declined from Dec. 2021 ($40.71 Mil) to Dec. 2022 ($38.06 Mil) but then increased from Dec. 2022 ($38.06 Mil) to Dec. 2023 ($75.23 Mil).

Tactile Systems Technology Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Tactile Systems Technology's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tactile Systems Technology Cash, Cash Equivalents, Marketable Securities Chart

Tactile Systems Technology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash, Cash Equivalents, Marketable Securities

Get a 7-Day Free Trial

53.38

58.56

40.71

38.06

75.23

Tactile Systems Technology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial															68.79	76.43	79.64	75.23	75.03

Tactile Systems Technology Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Tactile Systems Technology (NAS:TCMD) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Tactile Systems Technology Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Tactile Systems Technology's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Tactile Systems Technology (Tactile Systems Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tactile Systems Technology Inc (NAS:TCMD) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

3L3:Germany

Address

3701 Wayzata Boulevard, Suite 300, Minneapolis, MN, USA, 55416

Website

https://www.tactilemedical.com

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Executives

Boyd Vindell Washington	director	1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
Daniel L. Reuvers	director, officer: President and CEO	INTEGRA LIFESCIENCES CORPORATION, 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Sherri Lee Ferstler	officer: Senior VP, Sales	1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
William W Burke	director	3868 MOCKINGBIRD LN, DALLAS TX 75205
Kristie Burns	officer: Sr. VP Mktg & Clinical Affairs	3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Eric Pauls	officer: Senior VP, Sales	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Elaine M. Birkemeyer	officer: Chief Financial Officer	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Brent Moen	officer: Chief Financial Officer	3600 HOLLY LANE NORTH, SUITE 40, PLYMOUTH MN 55447
Carmen B Volkart	director	C/O MODULAR MEDICAL, INC., 16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Valerie L. Asbury	director	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
David Brent Shafer	director	2800 ROCKCREEK PARKWAY, NORTH KANSAS CITY MO 64117
Bryan Rishe	officer: Vice President, Sales	1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413
Deepti Jain	director	3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Sheri Louise Dodd	director	3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Gerald R. Mattys	director, officer: Chief Executive Officer	1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413